换一批
换一批Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
第一作者：
Enrica Antonia,Martino
第一单位：
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
作者：
Enrica Antonia,Martino [1]
;
Salvatore,Palmieri [2]
;
Monica,Galli [3]
;
Daniele,Derudas [4]
;
Roberto,Mina [5]
;
Roberta,Della Pepa [6]
;
Renato,Zambello [7]
;
Ernesto,Vigna [1]
;
Antonella,Bruzzese [1]
;
Silvia,Mangiacavalli [8]
;
Elena,Zamagni [9]
;
Catello,Califano [10]
;
Maurizio,Musso [11]
;
Concetta,Conticello [12]
;
Claudio,Cerchione [13]
;
Giuseppe,Mele [14]
;
Nicola,Di Renzo [15]
;
Massimo,Offidani [16]
;
Giuseppe,Tarantini [17]
;
Gloria Margiotta,Casaluci [18]
;
Angela,Rago [19]
;
Roberto,Ria [20]
;
Giuseppina,Uccello [21]
;
Gregorio,Barilà [22]
;
Gaetano,Palumbo [23]
;
Loredana,Pettine [24]
;
Iolanda Donatella,Vincelli [25]
;
Marino,Brunori [26]
;
Fabrizio,Accardi [27]
;
Valeria,Amico [28]
;
Angela,Amendola [29]
;
Raffaele,Fontana [30]
;
Velia,Bongarzoni [31]
;
Bernardo,Rossini [32]
;
Emilia,Cotzia [33]
;
Alessandro,Gozzetti [34]
;
Rita,Rizzi [35]
;
Nicola,Sgherza [36]
;
Giovanni,Reddiconto [15]
;
Antonio,Maroccia [37]
;
Luca,Franceschini [38]
;
Giuseppe,Bertuglia [39]
;
Davide,Nappi [13]
;
Emiliano,Barbieri [40]
;
Barbara,Gamberi [40]
;
Maria Teresa,Petrucci [41]
;
Francesco,Di Raimondo [12]
;
Antonino,Neri [42]
;
Fortunato,Morabito [43]
;
Pellegrino,Musto [35]
;
Massimo,Gentile [44]
作者单位：
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
[1]
Hematology Unit, Ospedale Cardarelli, Napoli, Italy.
[2]
Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni, Bergamo, Italy.
[3]
Department of Hematology, Businco Hospital, Cagliari, Italy.
[4]
Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
[5]
Department of Clinical Medicine and Surgery, Hematology Unit, University of Naples "Federico II", Naples, Italy.
[6]
Department of Medicine, University of Padova, Hematology Unit, Padova, Italy.;Veneto Institute of Molecular Medicine, Padova, Italy.
[7]
Division of Hematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
[8]
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.;Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
[9]
Onco-Hematology Unit, "A. Tortora" Hospital, Pagani, Italy.
[10]
Department of Oncology, Onco-Hematology Unit and TMO U.O.C., Palermo, Italy.
[11]
Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy.
[12]
Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
[13]
Department of Hematology, Hospital Perrino, Brindisi, Italy.
[14]
Department of Hematology, Hospital Vito Fazzi, Lecce, Italy.
[15]
Hematology Unit, AOU delle Marche, Ancona, Italy.
[16]
Hematology Unit, "Dimiccoli" Hospital, Barletta (BAT), Italy.
[17]
Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
[18]
UOSD Ematologia, Rome, Italy.
[19]
Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro Medical School, Internal Medicine "G. Baccelli"; CITEL, Bari, Italy.;Interdepartmental Centre for Research in Telemedicine, University of Bari Aldo Moro, Bari, Italy.
[20]
Hematology Department, G. Garibaldi Hospital, Catania, Italy.
[21]
Hematology Unit, Ospedale San Bortolo, Vicenza, Italy.
[22]
Department of Hematology, Hospital University Riuniti, Foggia, Italy.
[23]
Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
[24]
Department of Hemato-Oncology and Radiotherapy, Hematology Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
[25]
Internal Medicine, Ospedale Santa Croce, Fano, Italy.
[26]
Department of Hematology I, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
[27]
UOSD Ematologia, AORN San Pio, Benevento, Italy.
[28]
Hematology Unit, Azienda Ospedaliera Regionale "San Carlo", Potenza, Italy.
[29]
Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
[30]
Department of Hematology, San Giovanni-Addolorata Hospital, Rome, Italy.
[31]
Hematology and Cell Therapy Unit, IRCCS Istituto Tumori "Giovanni Paolo II" Bari, Bari, Italy.
[32]
Section of Hematology- Ospedale E. Muscatello-Augusta, Siracusa, Italy.
[33]
Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
[34]
Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy.;Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy.
[35]
Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy.
[36]
Hematology Unit - Ospedale dell'Angelo Azienda ULSS n.3 Serenissima, Venezia Mestre, Italy.
[37]
Lymphoproliferative Diseases Unit, Tor Vergata University Hospital, Rome, Italy.
[38]
Dipartimento di Oncologia ed Ematologia SC Ematologia 1 A.O. Citta' della Salute e della Scienza di Torino P.O. Molinette, Torino, Italy.
[39]
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
[40]
Department of Translational and Precision Medicine, Hematology Azienda Policlinico Umberto I Sapienza University of Rome, Rome, Italy.
[41]
Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
[42]
Gruppo Amici Dell'Ematologia Foundation-GrADE, Reggio Emilia, Italy.
[43]
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.;Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.
[44]
主题词
人类(Humans);多发性骨髓瘤(Multiple Myeloma);男(雄)性(Male);女(雌)性(Female);地塞米松(Dexamethasone);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);中年人(Middle Aged);沙立度胺(Thalidomide);回顾性研究(Retrospective Studies);随访研究(Follow-Up Studies);老年人, 80以上(Aged, 80 and over);成年人(Adult);肿瘤复发, 局部(Neoplasm Recurrence, Local);抗药性, 肿瘤(Drug Resistance, Neoplasm);存活率(Survival Rate)
DOI
10.1002/hon.3290
PMID
38818978
发布时间
2025-01-23
- 浏览1
Hematological oncology
Hematological oncology
e3290页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
